Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status
Clinical trial NCT00813943 · COMPLETED
Trial details
- NCT number
- NCT00813943
- Sponsor
- EMD Serono
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2013-02-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.